MANILA, Philippines – July 31, 2026 – Biotime, a leading innovator in the field of in vitro diagnostics (IVD), is pleased to announce its participation in Medical Philippines 2026, one of Southeast Asia's premier healthcare and medical technology exhibitions. The event will take place from August 19–21, 2026 at the SMX Convention Center in Manila, Philippines, where Biotime will be exhibiting at Booth 81. As the Philippines continues to invest in expanding and modernizing its healthcare infrastructure, Biotime is committed to supporting this growth by delivering reliable, accessible, and innovative diagnostic solutions to the region. This marks a significant opportunity for the company to strengthen its presence in the Southeast Asian market and connect with local partners, distributors, and healthcare professionals. What to Expect at Our Booth At Medical Philippines 2026, Biotime will showcase its two core technology platforms, designed to meet the diverse needs of laboratories and point-of-care settings: Chemiluminescence Immunoassay (CLIA) Platform: Featuring high sensitivity, excellent stability, and automated operation, this system is ideal for medium to large-scale laboratories requiring high-throughput testing capabilities. Fluorescence Immunoassay (FIA) Platform: Offering user-friendly operation and rapid response times, this platform is perfectly suited for primary healthcare centers, emergency departments, and point-of-care testing (POCT) environments. Built upon these platforms, Biotime has developed a comprehensive test menu covering critical disease areas, including cardiovascular risk assessment, diabetes management, infectious disease detection, and autoimmune and inflammatory markers. Connecting with Regional Partners "Medical Philippines provides an excellent platform for us to engage with healthcare professionals and distributors across Southeast Asia," said a spokesperson for Biotime. "We look forward to listening to local needs, exploring partnership opportunities, and demonstrating how our cost-effective, reliable IVD solutions can truly help laboratories in the region enhance their diagnostic capabilities and improve patient care." Visit Us in Manila Biotime invites all healthcare professionals, laboratory directors, distributors, and clinicians to visit Booth 81 at the SMX Convention Center. The Biotime team will be on hand to conduct live product demonstrations, provide technical consultations, and discuss how the company's diagnostic innovations can support better clinical decisions and operational efficiency. Let's connect in Manila and explore new collaborations to advance the future of laboratory medicine in Southeast Asia. See you at Booth #81!

Anaheim, CA – July 31, 2026 – Biotime, a leading innovator in the field of in vitro diagnostics (IVD), is pleased to announce its participation in the upcoming Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting & Clinical Lab Expo. The event, the world's premier gathering for laboratory medicine, will take place from July 28-30, 2026 at the Anaheim Convention Center in California, USA. Biotime will be exhibiting at Booth 845, where the company will demonstrate its commitment to advancing global healthcare through accessible and reliable diagnostic solutions . As a company with a robust portfolio of over 50 patents and a strong investment in research and development, Biotime continues to solidify its position as a trusted partner for laboratories worldwide . At ADLM 2026, Biotime will spotlight its cutting-edge technology platforms designed to meet the diverse needs of modern clinical laboratories: Chemiluminescence Immunoassay (CLIA) Platform: Featuring high sensitivity and high throughput, this automated system is ideal for medium- to large-scale laboratories seeking precision and efficiency. Fluorescence Immunoassay (FIA) Platform: Offering flexibility and user-friendly operation, this platform is perfectly suited for point-of-care testing (POCT) and primary care settings. Built upon these core technologies, Biotime has developed a comprehensive test menu addressing critical disease areas, including cardiovascular risk assessment, diabetes management, infectious disease detection, and autoimmune and inflammatory markers. "We are thrilled to bring our latest IVD innovations to the global stage in Anaheim," said a spokesperson for Biotime. "ADLM provides an unparalleled opportunity to connect with the global laboratory community. We look forward to demonstrating how our reliable, user-friendly diagnostic solutions can streamline workflows and elevate patient care." Biotime invites all lab directors, distributors, and clinicians to visit Booth 845 for live product demonstrations, technical consultations, and to explore new partnership opportunities. The company is dedicated to fostering collaborations that will advance the future of laboratory medicine and expand access to quality diagnostics 

Biotime is pleased to announce its participation in WHX & WHX Lab 2026, one of Southeast Asia's premier healthcare and laboratory exhibitions. The event will take place at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, where Biotime will be exhibiting at Booth L27.   As an innovator in the in vitro diagnostics (IVD) industry, Biotime is committed to delivering fast, accurate, and reliable diagnostic solutions to healthcare providers, laboratories, and distribution partners worldwide. At this year's show, the company will showcase two core technology platforms:   Chemiluminescence Immunoassay Platform–featuring high sensitivity and high throughput, designed for automated testing in medium to large-scale laboratories.   Fluorescence Immunoassay Platform–offering flexibility and user-friendly operation, well-suited for primary care and point-of-care testing (POCT) settings.   Built upon these platforms, Biotime has developed a comprehensive test menu covering multiple disease areas, including:   Thyroid function Cardiovascular markers Diabetes management Infectious diseases Tumor markers   The Bangkok exhibition represents a strategic step in Biotime's ongoing expansion into the Southeast Asian market. Beyond product demonstrations, the company looks forward to engaging with industry professionals from Thailand and neighboring countries, gaining insights into local healthcare needs, and exploring collaborative opportunities to strengthen regional diagnostic capabilities.   Whether you are a laboratory professional, distributor, or clinician, Biotime welcomes you to Booth L27 for technical presentations, product demonstrations, and in-depth discussions on the future of diagnostics.  

Biotime to Debut at Morocco Medical Expo 2026, Accelerating IVD Footprint in North Africa Biotime, a growing innovator in the in vitro diagnostics (IVD) field, today announced its participation in the Morocco Medical Expo 2026, one of North Africa’s leading healthcare and medical technology exhibitions. The event brings together medical device manufacturers, laboratory professionals, distributors, and healthcare decision‑makers from across the globe. This marks Biotime’s first exhibition appearance in Morocco, representing a significant step in the company’s global strategy to enter the African market. Leveraging Morocco’s strategic position as a healthcare trade gateway to North Africa, Biotime aims to connect with local and regional partners and explore new business opportunities. At the exhibition, Biotime will showcase two major technology platforms: Chemiluminescence Immunoassay Platform: Based on advanced nano‑magnetic particle chemiluminescence technology, delivering high sensitivity, a wide linear range, and excellent stability. It is ideal for medium‑ to high‑throughput automated laboratory testing. Fluorescence Immunoassay Platform: Easy to operate with rapid response times, well‑suited for primary healthcare centers and emergency scenarios – a perfect complement between point‑of‑care testing (POCT) and central laboratory workflows. Comprehensive IVD Solutions Covering Key Clinical Areas Leveraging these platforms, Biotime provides a full range of clinically validated assays and supporting solutions across several critical disease areas. “We are very excited to meet healthcare professionals from North Africa face‑to‑face for the first time at the Morocco Medical Expo,” said the Head of International Business at Biotime. “Morocco is an important gateway to Africa and the Middle East. This exhibition is not only a window to showcase our technological strengths, but also an opportunity to listen to local needs and build long‑term partnerships. We believe our cost‑effective, reliable IVD products will truly help laboratories in the region enhance their diagnostic capabilities.” See you in Morocco – together we explore new healthcare opportunities in North Africa!

Biotime to Showcase Leading Immunoassay and IVD Solutions at WHX Labs Dubai 2026 Biotime, an innovator in the in vitro diagnostics (IVD) field, is pleased to announce its participation in WHX Labs Dubai 2026, one of the Middle East's most influential exhibitions for the laboratory and diagnostics industry. The event gathers global industry leaders, experts, and key buyers to explore the future of laboratory medicine. As the Middle East continues to invest significantly in advanced laboratory medicine and healthcare infrastructure to enhance overall medical service capabilities, Biotime is committed to supporting this momentum. We offer a comprehensive portfolio of IVD solutions, featuring both chemiluminescence and fluorescence immunoassay platforms, designed for accuracy, efficiency, and real-world clinical needs. At this exhibition, Biotime's showcase will highlight: Advanced Immunoassay Platforms: Featuring our series of chemiluminescence and fluorescence immunoassay analyzers, demonstrating excellence in throughput, sensitivity, and reliability. Clinical Application-Focused Test Menu: Presenting comprehensive solutions covering diabetes, infectious diseases, tumor markers, and cardiovascular diagnostics, empowering laboratories to address critical healthcare challenges. Tailored Solutions for Regional Needs: Engaging with attendees to discuss scalable and flexible laboratory configurations designed to support the region's growing and evolving diagnostic demands. We look forward to connecting with industry professionals, partners, and clients from across the globe. Our team will be available to explore collaboration opportunities, exchange insights on the latest trends, and demonstrate how Biotime's solutions can enhance laboratory capabilities and patient care. Visit us at WHX Labs Dubai 2026 to discover the future of diagnostics. About Biotime: Biotime is a dedicated global provider of in vitro diagnostic solutions, specializing in the development, manufacturing, and distribution of immunoassay systems and reagents. Our mission is to deliver reliable, innovative, and accessible diagnostic tools that support healthcare professionals in improving patient outcomes worldwide.

Biotime Announces Participation in MEDICA 2025: Showcasing Innovative Diagnostic Solutions on the Global Stage DÜSSELDORF, Germany – Biotime, a leading innovator in the in vitro diagnostics (IVD) industry, is proud to announce its official participation in MEDICA 2025, the world’s premier medical trade fair. The event will take place from November 17 to 20, 2025, at the fairgrounds and congress center in Düsseldorf, Germany. Visitors are invited to explore Biotime’s latest advancements at Booth K62-2 in Hall 03. As a global gathering for medical technology, laboratory equipment, and diagnostic solutions, MEDICA provides an unparalleled platform for knowledge exchange, partnership building, and showcasing the future of healthcare. Biotime’s presence underscores its commitment to engaging with healthcare professionals, distributors, and industry leaders from across the globe. About Biotime: Advancing Diagnostics, Empowering Health Biotime has established itself as a trusted and pioneering manufacturer of high-performance IVD systems. With a mission to make reliable and accessible diagnostic solutions available worldwide, the company invests significantly in research and development. Its comprehensive product portfolio supports clinical laboratories, hospitals, and healthcare providers in delivering accurate and timely patient care across multiple disease areas. Spotlight on Innovations: What to Expect at Our Booth At MEDICA 2025, Biotime will feature a range of cutting-edge systems and comprehensive diagnostic panels designed to enhance clinical efficiency and patient outcomes. Key highlights include: Next-Generation Immunoassay Analyzers: Live demonstrations of our flagship chemiluminescence immunoassay (CLIA) and fluorescence immunoassay (FIA) systems, renowned for their precision, high throughput, and user-friendly operation. Integrated Diagnostic Solutions: A focused display on tailored testing panels for critical health areas: Diabetes Management: From monitoring to complication risk assessment. Infectious Diseases: Robust assays for improved detection and management. Tumor Markers: Supporting cancer screening and monitoring. Cardiovascular Health: Aiding in risk evaluation and disease management. Connect with Us in Düsseldorf The Biotime team looks forward to welcoming visitors for: Live product demonstrations and hands-on equipment experiences. Technical consultations with our application and engineering experts. Discussions on market trends, regulatory landscapes, and partnership opportunities to drive growth and expand access to quality diagnostics. Event Details: Event: MEDICA 2025 – World Forum for Medicine Dates: November 17–20, 2025 Location: Exhibition Center & Congress Center Düsseldorf, Germany Biotime Booth: Hall 03, Stand K62-2 Join us as we shape the future of diagnostics.

Biotime, a leading manufacturer of in vitro diagnostic (IVD) solutions, is pleased to announce its participation in the Indonesia Hospital Expo 2025, held from September 25th to 28th at the Indonesia Convention Exhibition (ICE) in BSD City. Visit us at Booth 355 to discover our latest advancements in medical technology and diagnostic systems. As one of the most significant healthcare exhibitions in Southeast Asia, the Indonesia Hospital Expo brings together industry professionals, healthcare providers, and innovators to promote the exchange of ideas and technologies that enhance patient care and medical services. Biotime is proud to be part of this important platform, demonstrating our ongoing commitment to supporting the regional healthcare ecosystem. At the expo, we will be featuring a comprehensive range of cutting-edge products designed to meet the evolving needs of modern medical diagnostics. Highlights include: Chemiluminescence and fluorescence immunoassay analyzers Integrated solutions for diabetes management Advanced assays for infectious disease detection, tumor markers, and cardiovascular diagnostics Our team of experts will be on hand to conduct live product demonstrations, discuss clinical applications, and provide insights into emerging industry trends. We welcome healthcare professionals, distributors, and partners to engage with us in exploring how our technologies can enhance diagnostic accuracy and operational efficiency. Biotime remains dedicated to advancing global health through reliable, innovative, and accessible diagnostic solutions. Our presence at this year’s Indonesia Hospital Expo underscores our mission to foster meaningful collaborations and contribute to the future of healthcare in Indonesia and beyond. We invite all attendees to join us at Booth 355 from September 25–28, 2025, at the Indonesia Convention Exhibition (ICE), BSD City. For further information, please contact: info@biotime.cn

Biotime is excited to announce its participation in the upcoming Medical Fair Thailand, taking place from September 10-12, 2025, at the Bangkok International Trade & Exhibition Centre (BITEC). This event is recognized as Southeast Asia’s premier international healthcare trade fair, providing a vital platform for advancing the medical and healthcare sector in the region. Since its inception in 2003, Medical Fair Thailand has established itself as a key event, alternating biennially with Medical Fair Asia in Singapore. This year, Biotime, as a pioneering manufacturer in the in vitro diagnostics (IVD) sector, is eager to showcase its latest innovations aimed at enhancing global health through advanced diagnostic solutions. Visitors can look forward to exploring our cutting-edge products, including: Chemiluminescence and Fluorescence Immunoassay Analyzers Diabetes Management Solutions Infectious Disease Detection Tools Tumor Marker Testing Systems Cardiovascular Diagnostics Our dedicated team will be present at Booth W01, ready to engage with attendees. We invite visitors to ask questions, witness in-depth product demonstrations, and receive personalized consultations regarding industry trends and applications. We are looking forward to welcoming all visitors and fostering meaningful connections that drive innovation in healthcare. Should you require any assistance or have inquiries prior to the event, please don’t hesitate to reach out to us! Join us in advancing healthcare solutions at Medical Fair Thailand 2025!